Plant Natural Flavonoids Against Multidrug Resistant Pathogens.

Song M, Liu Y, Li T, Liu X, Hao Z, Ding S, Panichayupakaranant P, Zhu K, Shen J. · 2021

Read Plant Natural Flavonoids Against Multidrug Resistant Pathogens. by Song M, Liu Y, Li T, Liu X, Hao Z, Ding S, Panichayupakaranant P, Zhu K, Shen J. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8336499.txt.

Introduction

Song and co-authors test plant flavonoids against multidrug-resistant bacteria. Resistant pathogens spread fast and strain the hunt for antibiotics. Natural products supply many prized antibacterial scaffolds.

Two flavonoids stood out: α-mangostin and isobavachalcone. A prenyl group tuned their activity, structure analysis showed. Both killed Gram-positive bacteria quickly. They also restored colistin's power against Gram-negative pathogens. Binding studies traced how they act on the cells. Such compounds could revive failing drugs. They may also seed new ones. The work joins chemistry to microbiology tightly. Structure and activity were linked compound by compound. The point is not just to name the size of the risk, but to show where wells, pipes, and plans can cut it down for the towns that need help most.

Catalog record

CREATORSong M, Liu Y, Li T, Liu X, Hao Z, Ding S, Panichayupakaranant P, Zhu K, Shen J.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE56 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8336499

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Plant Natural Flavonoids Against Multidrug Resistant Pathogens By Meirong Song, Ying Liu, Tingting Li, Xiaojia Liu, Zhihui Hao, Shuangyang Ding, Pharkphoom Panichayupakaranant, Kui Zhu, Jianzhong Shen Published in: Advanced Science DOI: 10.1002/advs.202100749 ABSTRACT Abstract The increasing emergence and dissemination of multidrug resistant (MDR) bacterial pathogens accelerate the desires for new antibiotics. Natural products dominate the preferred chemical scaffolds for the discovery of antibacterial agents. Here, the potential of natural flavonoids from plants against MDR bacteria, is demonstrated. Structure–activity relationship analysis shows the prenylation modulates the activity of flavonoids and obtains two compounds, α‐mangostin (AMG) and isobavachalcone (IBC). AMG and IBC not only display rapid bactericidal activity against Gram‐positive bacteria, but also restore the susceptibility of colistin against Gram‐negative pathogens. Mechanistic studies generally show such compounds bind to the phospholipids of bacterial membrane, and result in the dissipation of proton motive force and metabolic perturbations, through distinctive modes of action. The efficacy of AMG and IBC in four models associated with infection or contamination, is demonstrated. These results suggest that natural products of plants may be a promising and underappreciated reservoir to circumvent the existing antibiotic resistance. Keywords: bacterial membrane, drug discovery, flavonoids, isopentenyl, multidrug‐resistant bacteria INTRODUCTION Antibiotics are definitely the cornerstone of modern medical system.[ 1 ] Emergence of multidrug‐resistant (MDR) bacteria at alarming rates is constantly paralyzing the health system worldwide.[ 2 , 3 , 4 , 5 ] Development of antibiotics with distinctive mechanisms is vital to win such arms race. Thus, novel efficient antibacterial agents and alternative strategies are urgently required to fill the void of antibiotic discovery and development. Compared to the synthetic chemotherapeutic drugs and other potential approaches,[ 6 , 7 , 8 ] natural antibacterial agents possess the advances in accessibility,[ 9 , 10 ] structural diversity,[ 11 ] robust activity,[ 12 ] and distinct modes of action.[ 13 ] Natural antibacterial agents and the analogues still dominate the multiple classes of antibiotics routinely used in clinic, including β‐lactams, tetracyclines, aminoglycosides, and polypeptides. The tremendous chemo‐diversity of natural products provides versatile scaffolds for antibiotic discovery, however, such natural compounds were largely screened from soil‐dwelling microorganisms based on Waksman platform.[ 1 ] Although recent advances in biotechnologies make it possible to continually discover new antibiotics from untraditional terrestrial microbes[ 6 , 9 , 14 , 15 , 16 ] and drug repurposing,[ 17 , 18 , 19 ] the dramatically increased rediscovery rate of known antibiotics portends the declining number of drugs introduced to the clinic,[ 13 ] lagging far behind the prompt dissemination of MDR pathogens globally. Therefore, the unexplored sources have been extended to mine new antibiotics from humans,[ 7 , 20 , 21 ] insects,[ 22 ] and other sources.[ 11 , 23 , 24 ] Plants account for the most biomass on our planet.[ 25 ] The discovery of bioactive molecules of plant origins has contributed to great progresses in drug development for various purposes.[ 26 , 27 , 28 ] For instance, the chemical repertoire of herbs exhibits enormous natural compounds for the treatments of infection, particularly quinine and artemisinin against malaria.[ 29 ] Lacking mammalian immune systems, plants evolutionarily optimize privileged drug‐like molecules to combat bacterial diseases.[ 30 ] The largely untapped chemical diversity of traditional medicinal herbs has been historically neglected since the golden era of antibiotic discovery. Recently, by analyzing more than 183 natural products with antibacterial activity from plants, researchers found that plant natural products represent a promising source of antibacterial lead compounds that could help fill the drug discovery pipeline in response to the growing antibiotic resistance.[ 31 ] We reasoned that an alternative approach is to explore the untapped chemo‐diversity of plants for antibiotic discovery against MDR pathogens. Plants are abundant in a diverse group of polyphenolic flavonoids.[ 32 , 33 ] The ubiquitous flavonoids in medicinal herbs, accord for the multifaceted use of pharmaceutical, nutritional, and agrochemical interests.[ 13 , 34 , 35 , 36 , 37 ] In this work, structure–activity relationship (SAR) analysis of flavonoids derived from 271 kinds of medicinal plants showed that certain isopentenylated flavonoids such as α‐mangostin (AMG) and isobavachalcone (IBC) were efficacious against antibiotic‐resistant priority Gram‐positive and Gram‐negative pathogens with permeabilized outer membrane (Figure 1A). Mechanistic studies revealed that both AMG and IBC display rapid bactericidal activities through distinctive modes of action. Lastly, such flavonoids were further demonstrated in four models of MDR bacterial infection/contamination. Our findings suggest that structurally distinct antibacterial botanic molecules are an untapped source for discovering novel classes of drugs to circumvent the increasing prevalence of antibiotic resistance. [Figure: AMG and IBC show robust antibacterial activity against Gram‐positive bacteria and reverse colistin resistance in Gram‐negative bacteria. A) The scheme of screening antibacterial compounds in this study. 85 flavonoid compounds derived from 271 medicinal plants were collected and the antibacterial activities against Gram‐positive and Gram‐negative bacteria were determined by the broth micro‐dilution method according to the CLSI 2021 guideline. The SAR was analyzed and potent antibiotic candidates were chosen. Finally, the mode of action (MOA) and efficacy in vivo were clarified. B) Chemical structures of the skeleton of flavonoids and the five lead compounds; the skeleton of flavonoids was marked in blue and the isopentenyl group was in red. C) Synergy of AMG or IBC with different classes of antibiotics against E. coli B2. FICI were determined by chequerboard microdilution assays. Synergy is defined as a FICI ≤ 0.5. AMP, ampicillin; CRO, ceftriaxone; MER, meropenem; ERY, erythromycin; GEN, gentamicin; OFX, ofloxacin; COL, colistin; RIF, rifampicin; TGC, tigecycline; TET, tetracycline; and FFC, florfenicol. Data represent two biological replicates.] RESULTS Screening of Flavonoids and the SAR Analysis 2.1. Flavonoids share a common skeleton with the 15‐carbon 2‐phenyl‐chromone core (C6—C3—C6 system, Figure 1B),[ 38 ] which are further divided into nearly 20 groups.[ 33 ] Antibacterial activities of flavonoids have been controversially reported;[ 13 , 39 , 40 ] it remains unclear to what extent the side‐chain modification of flavonoids affects the activity. Since the presence of prenyl‐moiety can sharply increase the lipophilicity of natural products,[ 41 , 42 ] we hypothesized whether and how the prenylation modulates the activity of flavonoids through attachment to bacterial membrane. The largely unexplored bacterial membrane remains an intriguing potential target for antibiotic discovery.[ 18 , 43 , 44 ] Therefore, 85 typical flavonoids including 23 flavones, 20 isoflavones, 13 flavanones, 10 chalcones, and 19 xanthones, were collected for antibacterial tests, according to the CLSI 2021 guideline.[ 45 ] Interestingly, more than 40% compounds (37/85) were active against Staphylococcus aureus (S. aureus) ATCC 29213 and methicillin‐resistant S. aureus (MRSA T144), with the minimum inhibitory concentrations (MICs) ranging from 1 to 8 µg mL−1 (Table S2, Supporting Information). Although no direct antibacterial effects on Escherichia coli (E. coli) were observed, 35.2% compounds (30/85) restored the susceptibility of the model MDR E. coli B2 isolate[ 8 ] in the presence of colistin. Interestingly, all the flavonoids that showed antibacterial activity against MRSA T144 are prenylated (37/37) (Table S2, Supporting Information). The number of prenyl groups attached to the backbone affects the activity as well, based on SAR analysis. Compared to monoprenyl flavonoids (33.3%, 15/45) and triprenyl groups modified ones (50%, 4/8), the prenylation with two groups (69.2%, 18/26) dominates the active prenylated flavonoids.

Read the complete text